Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vitrolife wins Canadian approval for Steen Solution study
The study, which has been designed in consultation with the FDA, is planned for quarters three to four of 2008 and will be the key element in the
The study, which has been designed in consultation with the FDA, is planned for quarters three to four of 2008 and will be the key element in the
As part of Shape, UCB intends to reduce its workforce by 2000 positions throughout the world, representing approximately 17% of its world-wide workforce. The company plans to achieve
Ron Howell, CEO and president of HST Global, said: “Through the use of the EBITDA Capital resources we at HST Global can focus on the issue of bringing
Most recently, Dr Solomon served as COO of Vital Sensors. Dr Solomon studied medicine and received his doctorate at Cornell University Medical College and the Sloan-Kettering division of
As a result of these actions Replidyne will suspend further development activities of REP3123, its investigational agent for the treatment of Clostridium difficile bacteria and C difficile infection,
The main focus of the program is to show how technology can assist in monitoring patients from their home in modern life with the main emphasis being to
Ms Corkern has been with the company for two years, serving as COO, then interim CEO. She also serves on Talyst’s board of directors. She has more than
The Glivec submissions are based on data from a Phase III, double-blind, randomized, multicenter, international study of more than 700 gastrointestinal stromal tumor (GIST) patients who had surgery
The announcement is said to be an important development for patients because the National Institute for Health and Clinical Excellence (NICE) determines access to medicines in England and
CE mark approval means that the product has been deemed safe and effective for the treatment of acute myocardial infarction and can now be promoted for this indication